Post-marketing observational program of the effectiveness of fluvoxamine for the treatment of depression in patients with neurological disorders: the FRIENDS study
Nikolay N Yahno,1 Anastasia V Fedotova2 1Neurology Department, I.M. Sechenov First Moscow State Medical University, 2Neurology Department, Additional Professional Education Faculty, Pirogov Russian National Research Medical University, Moscow, Russian Federation Abstract: In a prospective, non-bli...
Guardado en:
Autores principales: | Yahno NN, Fedotova AV |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a5f45784e604fa6bd570a5df88cc339 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
por: Yoshimura R, et al.
Publicado: (2017) -
The Effect Of Fluvoxamine On Sleep Architecture Of Depressed Patients With Insomnia: An 8-Week, Open-Label, Baseline-Controlled Study
por: Hao Y, et al.
Publicado: (2019) -
Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive–compulsive disorder
por: Hasanpour H, et al.
Publicado: (2018) -
Impact of non-motor symptoms in Parkinson’s disease: a PMDAlliance survey
por: Hermanowicz N, et al.
Publicado: (2019) -
Adaptive Affect: The Nature of Anxiety and Depression
por: Morris DW
Publicado: (2019)